title: The advantages of concurrent chemoradiation after neoadjuvant chemotherapy for locally advanced cervical carcinoma.
authors.forename: Alfonso
authors.initials: A
authors.lastname: Dueñas-González
authors.forename: Lesbia
authors.initials: L
authors.lastname: Rivera
authors.forename: Aida
authors.initials: A
authors.lastname: Mota
authors.forename: Carlos
authors.initials: C
authors.lastname: López-Graniel
authors.forename: Alberto
authors.initials: A
authors.lastname: Guadarrama
authors.forename: Aarón
authors.initials: A
authors.lastname: González
authors.forename: Gregorio
authors.initials: G
authors.lastname: Chanona
authors.forename: Paula
authors.initials: P
authors.lastname: Cabrera
authors.forename: Jaime
authors.initials: J
authors.lastname: de la Garza
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D002945:Cisplatin / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*
chemical_list: D000970:Antineoplastic Agents; D002945:Cisplatin